301 related articles for article (PubMed ID: 24037812)
1. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
[TBL] [Abstract][Full Text] [Related]
3. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL
Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042
[TBL] [Abstract][Full Text] [Related]
4. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.
Dittus K; Geller B; Weaver DL; Kerlikowske K; Zhu W; Hubbard R; Braithwaite D; O'Meara ES; Miglioretti DL;
J Gen Intern Med; 2013 Nov; 28(11):1454-62. PubMed ID: 23760741
[TBL] [Abstract][Full Text] [Related]
5. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
[TBL] [Abstract][Full Text] [Related]
6. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
[TBL] [Abstract][Full Text] [Related]
7. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
[TBL] [Abstract][Full Text] [Related]
8. Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency.
Sprague BL; Chen S; Miglioretti DL; Gard CC; Tice JA; Hubbard RA; Aiello Bowles EJ; Kaufman PA; Kerlikowske K
JAMA Netw Open; 2023 Feb; 6(2):e230166. PubMed ID: 36808238
[TBL] [Abstract][Full Text] [Related]
9. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
10. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography.
Ho TH; Bissell MCS; Kerlikowske K; Hubbard RA; Sprague BL; Lee CI; Tice JA; Tosteson ANA; Miglioretti DL
JAMA Netw Open; 2022 Mar; 5(3):e222440. PubMed ID: 35333365
[TBL] [Abstract][Full Text] [Related]
11. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
Canelo-Aybar C; Posso M; Montero N; Solà I; Saz-Parkinson Z; Duffy SW; Follmann M; Gräwingholt A; Giorgi Rossi P; Alonso-Coello P
Br J Cancer; 2022 Mar; 126(4):673-688. PubMed ID: 34837076
[TBL] [Abstract][Full Text] [Related]
12. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
13. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
Schousboe JT; Kerlikowske K; Loh A; Cummings SR
Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
[TBL] [Abstract][Full Text] [Related]
15. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.
Stout NK; Lee SJ; Schechter CB; Kerlikowske K; Alagoz O; Berry D; Buist DS; Cevik M; Chisholm G; de Koning HJ; Huang H; Hubbard RA; Miglioretti DL; Munsell MF; Trentham-Dietz A; van Ravesteyn NT; Tosteson AN; Mandelblatt JS
J Natl Cancer Inst; 2014 Jun; 106(6):dju092. PubMed ID: 24872543
[TBL] [Abstract][Full Text] [Related]
16. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
[TBL] [Abstract][Full Text] [Related]
17. Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening.
Moorman SEH; Pujara AC; Sakala MD; Neal CH; Maturen KE; Swartz L; Egloff H; Helvie MA
AJR Am J Roentgenol; 2021 Jul; 217(1):40-47. PubMed ID: 33955776
[No Abstract] [Full Text] [Related]
18. Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.
Winch CJ; Sherman KA; Boyages J
Breast Cancer Res Treat; 2015 Jan; 149(1):211-21. PubMed ID: 25476499
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated with False Positive Results on Screening Mammography in a Population of Predominantly Hispanic Women.
McGuinness JE; Ueng W; Trivedi MS; Yi HS; David R; Vanegas A; Vargas J; Sandoval R; Kukafka R; Crew KD
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):446-453. PubMed ID: 29382701
[No Abstract] [Full Text] [Related]
20. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]